PRZOOM - /newswire/ - Goettingen, Germany, 2012/04/19 - At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved all board proposals by a large majority - Sartorius-Stedim.com.

Annual Shareholders’ Meeting passes resolution to pay dividends of 0.82 euro per preference share and 0.80 euro per ordinary share | Share owner representatives elected to the Supervisory Board | Supervisory Board and Executive Board granted discharge by a large majority

Thus, the Annual Shareholders' Meeting passed the resolution to pay dividends of 0.82 euro per preference share (previous year: 0.62 euro) and 0.80 euro per ordinary share (previous year: 0.60 euro). Accordingly, the total amount of dividends to be paid out will rise 32.8% to 13.8 million euros from a year earlier.

During the regular election of share owner representatives to the Supervisory Board, shareholders re-elected Prof. Dr. Dres. h.c. Arnold Picot, Dr. Dirk Basting, Dr. Lothar Kappich and Prof. Dr. Gerd Krieger. Prof. Dr. Klaus Rüdiger Trützschler and Prof. Dr. Thomas Scheper, were elected for the first time. Prof. Dr. Trützschler has been a member of the Supervisory Board since November 2011. He had been appointed by court order after the death of Supervisory Board member Dr. Michael Schulenburg. Prof. Dr. Thomas Scheper was proposed for election because Prof. Dr. rer. nat. Dr.-Ing. E.h. Heribert Offermanns, who had been a member of the Sartorius Supervisory Board since 2000, was no longer available to serve for a further term on the grounds of age. The new Supervisory Board will serve for a term of five years.

Furthermore, the Annual Shareholders’ Meeting granted discharge to the Supervisory Board and to the Executive Board by a considerable majority. Some 300 share owners representing nearly 60% of the voting share capital attended this year’s Annual Shareholders’ Meeting.

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius (sartorius-stedim.com) reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

Agency / Source: Sartorius Stedim Biotech S.A.

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]